Alabama Medical Board Warns Doctors Against 14 Non-FDA Peptides as Interest Surges
Updated
Updated · 1819 News · Jun 6
Alabama Medical Board Warns Doctors Against 14 Non-FDA Peptides as Interest Surges
3 articles · Updated · 1819 News · Jun 6
Summary
Alabama's medical board issued a notice telling physicians they cannot prescribe, recommend, supply or administer research-grade peptides that lack FDA approval for human use.
The warning was framed as a proactive patient-safety step after rising inquiries from both patients and clinicians, with the board citing online health claims and growing demand for guidance.
The board said doctors also cannot route peptide purchases or administration through CRNPs, CNMs or PAs to avoid their duty of care under state law.
No specific injury triggered the alert, but Alabama suspended a physician assistant's license in March over unapproved peptides and worked with the attorney general in 2025 to shut a Cullman clinic.
The notice lands as HHS Secretary Robert F. Kennedy Jr. pushes to loosen federal restrictions on about 14 popular peptide injections, a move backed by Senator Tommy Tuberville.